All In MedTech

Device Trial Radar · NCT06999304

Pilot TMS in Mild TBI

Personalized Accelerated Theta Burst Transcardial Magnetic Stimulation in Mild Traumatic Brain Injury

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Jun 18, 2025

Primary completion

Apr 2027

Study completion Jul 2027

Sponsor

Lead sponsor
HealthPartners InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 31, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Persistent post-concussive symptoms (PPCS) involve an array of physical, cognitive, and behavioral symptoms lasting more than a month after mild traumatic brain injury (mTBI). 34-44% of people with mTBI or concussion present with a considerable burden of PPCS 3-6 months after injury. There is currently no standardized treatment for PPCS, nor FDA approved medication for any neuropsychiatric or neurocognitive symptoms associated with mTBI. Transcranial magnetic stimulation (TMS) shows promise as a treatment for PPCS; however, the current one-size-fits-all approach does not address the heterogeneity of symptoms. We propose utilization of resting state functional MRI (rs-fMRI) guided rTMS to target personalized brain networks burdened with PPCS.

Conditions

  • Persistent Post Concussive Headache
  • Mild Traumatic Brain Injury

Interventions

  • Intermittent theta burst stimulationDevice

    MagVenture TMS Therapy active coil with theta burst stimulation. Resting motor threshold: 80%; Intermittent theta burst - Number of pulses per session: 1200 pulses; Inter-train interval: 8 seconds; Pulse frequency in burst: 50 Hertz; Continuous theta burst - Number of pulses per session: 1800 pulses; Pulse frequency in burst: 50 Hertz

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of participants with anomalous parcellations - developing the method of personalization of TMS for PPCSTime frame: baseline
  2. Anomalous parcellations - developing the method of personalization of TMS targets for PPCSTime frame: baseline
  3. Distribution of complaints for PPCSTime frame: baseline

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • HealthPartners Neuroscience Center

    Saint Paul, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.